Senti Biosciences Accounts Payable

Senti Biosciences (SNTI) currently reports a accounts payable of $2.2M as of June 2026. That compares with $1M in the prior-year period — up 120.4% year over year. Use the charts on this page to explore Senti Biosciences's accounts payable history and peer comparisons.

Senti Biosciences's accounts payable increased from $1M to $2.2M — a 120.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Senti Biosciences reported $2.2M in accounts payable as of June 2026. That compares with $1M in the prior-year period — up 120.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $2.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Senti Biosciences, and consider following SNTI for alerts when major investors trade the stock.